Psyllium and Janumet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Psyllium (blond psyllium) and Janumet (metformin hydrochloride; sitagliptin phosphate). Common drug interactions include diabetes mellitus inadequate control among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Psyllium and Janumet. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Psyllium?

Psyllium has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 4,262 Psyllium users. Check the latest studies of Psyllium.

What is Janumet?

Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 25,023 Janumet users. Check the latest studies of Janumet.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

22 people who take Psyllium and Janumet together, and have interactions are studied.

Psyllium and Janumet drug interactions.

What are the common drug interactions of Psyllium and Janumet, by gender? *:

female:

  1. Diabetes mellitus inadequate control
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Blood pressure inadequately controlled
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Depressed mood
  7. Drug ineffective
  8. Exercise tolerance decreased
  9. Hypertension (high blood pressure)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Abdominal distension
  2. Cardiac failure congestive
  3. Suicidal ideation
  4. Weight decreased
  5. Blood glucose increased
  6. Blood triglycerides increased
  7. Cardiac failure
  8. Cataract (clouding of the lens inside the eye)
  9. Chronic kidney disease
  10. Diarrhoea

What are the common drug interactions of Psyllium and Janumet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety disorder
  2. Arthralgia (joint pain)
  3. Back pain
  4. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  5. Blood cholesterol increased
  6. Chest pain
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Depression
  9. Diabetes mellitus inadequate control
  10. Essential hypertension (primary hypertension)

50-59:

  1. Abdominal distension
  2. Cardiac failure congestive
  3. Dysphemia (stammering or stuttering)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Liver disorder (liver diseases)
  6. Peripheral swelling
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Stress
  10. Suicidal ideation

60+:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Blood pressure inadequately controlled
  3. Oedema peripheral (superficial swelling)
  4. Peripheral swelling
  5. Abdominal discomfort
  6. Decreased appetite
  7. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  8. Hyperglycaemic hyperosmolar nonketotic syndrome (too much sugar (glucose) in your blood)
  9. Pyrexia (fever)
  10. Weight decreased

What are the existing conditions these people have? *

  1. Pain: 11 people, 50.00%
  2. Cough: 9 people, 40.91%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 40.91%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 8 people, 36.36%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 8 people, 36.36%
  6. Psoriasis (immune-mediated disease that affects the skin): 8 people, 36.36%
  7. Osteoporosis (bones weak and more likely to break): 8 people, 36.36%
  8. Oedema (fluid collection in tissue): 8 people, 36.36%
  9. Gout (uric acid crystals building up in the body): 8 people, 36.36%
  10. High Blood Pressure: 8 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Psyllium and Janumet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Psyllium and Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Psyllium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Psyllium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Janumet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on blond psyllium and metformin hydrochloride; sitagliptin phosphate (the active ingredients of Psyllium and Janumet, respectively), and Psyllium and Janumet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: